Literature DB >> 10899645

Identification of risk groups in hepatoblastoma--another step in optimising therapy.

D von Schweinitz1.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10899645     DOI: 10.1016/s0959-8049(00)00138-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  5 in total

1.  Treatment outcomes for hepatoblastoma: an institution's experience over two decades.

Authors:  J P Ang; J A Heath; S Donath; S Khurana; A Auldist
Journal:  Pediatr Surg Int       Date:  2006-11-21       Impact factor: 1.827

Review 2.  [Current status of diagnosis and treatment of hepatoblastoma].

Authors:  Purificación García-Miguel; Manuel López Santamaría
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

3.  Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Rebecka L Meyers; Jon R Rowland; Mark Krailo; Zhengjia Chen; Howard M Katzenstein; Marcio H Malogolowkin
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

4.  Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.

Authors:  Rosa Nguyen; M Beth McCarville; April Sykes; Shenghua Mao; Jianrong Wu; Max R Langham; Wayne L Furman
Journal:  Int J Clin Oncol       Date:  2018-05-09       Impact factor: 3.402

5.  Experience of treating pediatric hepatoblastoma at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia - Timely surgical intervention playing a key role.

Authors:  Ibrahim AlFawaz; Basheer Ahmed; Afshan Ali; Mouhab Ayas; Amani AlKofide; Zakaria Habib; Khawar Siddiqui
Journal:  Int J Pediatr Adolesc Med       Date:  2020-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.